Issn Print: 0027-8874
Publication Date: 2017/06/01
Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer
Nataniel H. Lester-Coll; Skyler Johnson; William J. Magnuson; Samuel Z. Goldhaber; David J. Sher; Anthony V. D’Amico; James B. Yu
Author Information: : Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT (NHLC, SJ, WJM, JBY); Cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (SZG); Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX (DJS); Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA (AVD).
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.